Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 5 de 5
Filter
1.
FASEB J ; 35(1): e21138, 2021 01.
Article in English | MEDLINE | ID: mdl-33184932

ABSTRACT

Appropriate migration of cytotoxic T effector cells into the tumors is crucial for their antitumor function. Despite the controversial role of PI3K-Akt in CD8+ T cell mTORC1 activation, a link between Akt-mTORC1 signaling and CD8+ trafficking has been demonstrated. We have recently discovered that TCR-induced calcineurin activates DAPK1, which interacts with TSC2 via its death domain and phosphorylates TSC2 via its kinase domain to mediate mTORC1 activation in CD8+ T cells. However, whether DAPK1 regulates CD8+ trafficking into tumors remains unclear. Here, using pharmacological inhibitor and genetic approaches, we found that like rapamycin, inhibition of DAPK1 activity led to enhanced expression of the homing receptors CD62L and CCR7. Deletion of either kinase domain or death domain in the T cell compartment reduced the T cell activation and maintained the expression of CD62L and CCR7. DAPK1-DD-deficient mice were more susceptible to tumor growth and deficiency of DAPK1 activity significantly reduced the migratory ability of CD8+ into the tumors. These data revealed a crucial role of DAPK1-mTORC1 in mediating CD8+ trafficking and antitumor function.


Subject(s)
CD8-Positive T-Lymphocytes/immunology , Cell Movement/immunology , Death-Associated Protein Kinases/immunology , Immunity, Cellular , Lymphocyte Activation , Neoplasms, Experimental/immunology , Animals , CD8-Positive T-Lymphocytes/pathology , Cell Line, Tumor , Death-Associated Protein Kinases/genetics , Mice , Mice, Knockout , Neoplasms, Experimental/genetics , Neoplasms, Experimental/pathology
2.
Nat Commun ; 7: 11904, 2016 06 17.
Article in English | MEDLINE | ID: mdl-27312851

ABSTRACT

Death-associated protein kinase (DAPK) is a tumour suppressor. Here we show that DAPK also inhibits T helper 17 (Th17) and prevents Th17-mediated pathology in a mouse model of autoimmunity. We demonstrate that DAPK specifically downregulates hypoxia-inducible factor 1α (HIF-1α). In contrast to the predominant nuclear localization of HIF-1α in many cell types, HIF-1α is located in both the cytoplasm and nucleus in T cells, allowing for a cytosolic DAPK-HIF-1α interaction. DAPK also binds prolyl hydroxylase domain protein 2 (PHD2) and increases HIF-1α-PHD2 association. DAPK thereby promotes the proline hydroxylation and proteasome degradation of HIF-1α. Consequently, DAPK deficiency leads to excess HIF-1α accumulation, enhanced IL-17 expression and exacerbated experimental autoimmune encephalomyelitis. Additional knockout of HIF-1α restores the normal differentiation of Dapk(-/-) Th17 cells and prevents experimental autoimmune encephalomyelitis development. Our results reveal a mechanism involving DAPK-mediated degradation of cytoplasmic HIF-1α, and suggest that raising DAPK levels could be used for treatment of Th17-associated inflammatory diseases.


Subject(s)
Death-Associated Protein Kinases/genetics , Encephalomyelitis, Autoimmune, Experimental/genetics , Hypoxia-Inducible Factor 1, alpha Subunit/genetics , Hypoxia-Inducible Factor-Proline Dioxygenases/genetics , Th17 Cells/immunology , Animals , Death-Associated Protein Kinases/deficiency , Death-Associated Protein Kinases/immunology , Encephalomyelitis, Autoimmune, Experimental/immunology , Encephalomyelitis, Autoimmune, Experimental/pathology , Gene Expression Regulation , HEK293 Cells , HeLa Cells , Humans , Hydroxylation , Hypoxia-Inducible Factor 1, alpha Subunit/immunology , Hypoxia-Inducible Factor-Proline Dioxygenases/antagonists & inhibitors , Hypoxia-Inducible Factor-Proline Dioxygenases/immunology , Interleukin-17/genetics , Interleukin-17/immunology , Jurkat Cells , Mice , Mice, Knockout , Myelin-Oligodendrocyte Glycoprotein/administration & dosage , Peptide Fragments/administration & dosage , Pertussis Toxin/administration & dosage , Proline/metabolism , Proteasome Endopeptidase Complex , Proteolysis , RNA, Small Interfering/genetics , RNA, Small Interfering/metabolism , Signal Transduction , T-Lymphocytes, Regulatory/drug effects , T-Lymphocytes, Regulatory/immunology , T-Lymphocytes, Regulatory/pathology , Th17 Cells/drug effects , Th17 Cells/pathology
3.
Cell Rep ; 14(7): 1581-1589, 2016 Feb 23.
Article in English | MEDLINE | ID: mdl-26876169

ABSTRACT

Pathogens attack host cells by deploying toxins that perturb core host processes. Recent findings from the nematode C. elegans and other metazoans indicate that surveillance or "effector-triggered" pathways monitor functioning of these core processes and mount protective responses when they are perturbed. Despite a growing number of examples of surveillance immunity, the signaling components remain poorly defined. Here, we show that CEBP-2, the C. elegans ortholog of mammalian CCAAT-enhancer-binding protein gamma, is a key player in surveillance immunity. We show that CEBP-2 acts together with the bZIP transcription factor ZIP-2 in the protective response to translational block by P. aeruginosa Exotoxin A as well as perturbations of other processes. CEBP-2 serves to limit pathogen burden, promote survival upon P. aeruginosa infection, and also promote survival upon Exotoxin A exposure. These findings may have broad implications for the mechanisms by which animals sense pathogenic attack and mount protective responses.


Subject(s)
CCAAT-Enhancer-Binding Proteins/immunology , Caenorhabditis elegans Proteins/immunology , Caenorhabditis elegans/immunology , Death-Associated Protein Kinases/immunology , Host-Pathogen Interactions , Immunologic Surveillance , Pseudomonas aeruginosa/growth & development , ADP Ribose Transferases/biosynthesis , ADP Ribose Transferases/immunology , Animals , Bacterial Toxins/biosynthesis , Bacterial Toxins/immunology , CCAAT-Enhancer-Binding Proteins/antagonists & inhibitors , CCAAT-Enhancer-Binding Proteins/genetics , Caenorhabditis elegans/genetics , Caenorhabditis elegans/microbiology , Caenorhabditis elegans Proteins/antagonists & inhibitors , Caenorhabditis elegans Proteins/genetics , Death-Associated Protein Kinases/antagonists & inhibitors , Death-Associated Protein Kinases/genetics , Exotoxins/biosynthesis , Exotoxins/immunology , Gene Expression Regulation/immunology , Immunity, Innate , Pseudomonas aeruginosa/immunology , RNA, Small Interfering/genetics , RNA, Small Interfering/metabolism , Signal Transduction , Survival Rate , Virulence Factors/biosynthesis , Virulence Factors/immunology , Pseudomonas aeruginosa Exotoxin A
4.
Apoptosis ; 19(2): 357-63, 2014 Feb.
Article in English | MEDLINE | ID: mdl-24185831

ABSTRACT

Death-associated protein kinase (DAPK) is a tumor suppressor and negatively regulates several activation signals. Consistent with its potential anti-inflammatory activity, DAPK promotes the formation of IFN-γ-activated inhibitor of translation (GAIT) complex that suppresses the translation of selected inflammatory genes. DAPK has been found to inhibit tumor necrosis factor-α (TNF-α)- or lipopolysaccharides (LPS)-induced NF-κB activation and pro-inflammatory cytokine expression. Inflammation is always associated with T cell activation, while DAPK attenuates T cell activation by a selective suppression in T cell receptor-triggered NF-κB activation. Recent studies, however, also reveal a contribution of DAPK to pro-inflammatory processes. DAPK is shown to mediate pro-inflammatory signaling downstream of TNF-α, LPS, IL-17, or IL-32. In addition, DAPK is required for the full formation of NLRP3 inflammasome, essential for the generation of IL-1ß and IL-18. These results suggest the complicated role of DAPK in the regulation of inflammation that is likely dependent on cell types and environmental cues.


Subject(s)
Death-Associated Protein Kinases/metabolism , Inflammation/metabolism , Animals , Cytokines/metabolism , Death-Associated Protein Kinases/immunology , Down-Regulation , Humans , Inflammasomes/metabolism , Inflammation/immunology , Intracellular Signaling Peptides and Proteins/metabolism , NF-kappa B/immunology , NF-kappa B/metabolism , Signal Transduction , T-Lymphocytes/immunology , T-Lymphocytes/metabolism
5.
Apoptosis ; 19(2): 392-7, 2014 Feb.
Article in English | MEDLINE | ID: mdl-24242918

ABSTRACT

The death associated protein kinases (DAPK) are a phylogenetically widespread family of calcium-regulated serine/threonine kinases, initially identified from their roles in apoptosis. Subsequent studies, principally in vertebrate cells or models, have elucidated the functions of the DAPK family in autophagy and tumor suppression. Invertebrate genetic model organisms such as Drosophila and C. elegans have revealed additional functions for DAPK and related kinases. In the nematode C. elegans, the sole DAPK family member DAPK-1 positively regulates starvation-induced autophagy. Genetic analysis in C. elegans has revealed that DAPK-1 also acts as a negative regulator of epithelial innate immune responses in the epidermis. This negative regulatory role for DAPK in innate immunity may be analogous to the roles of mammalian DAPK in inflammatory responses.


Subject(s)
Caenorhabditis elegans Proteins/metabolism , Caenorhabditis elegans/enzymology , Death-Associated Protein Kinases/metabolism , Actins/metabolism , Animals , Autophagy , Caenorhabditis elegans/anatomy & histology , Caenorhabditis elegans/immunology , Caenorhabditis elegans Proteins/immunology , Death-Associated Protein Kinases/immunology , Drosophila melanogaster/anatomy & histology , Drosophila melanogaster/enzymology , Drosophila melanogaster/growth & development , Epidermal Cells , Epidermis/enzymology , Epidermis/growth & development , Epithelium/enzymology , Epithelium/growth & development , Humans , Immunity, Innate , Phylogeny , Species Specificity , Vertebrates , Wound Healing
SELECTION OF CITATIONS
SEARCH DETAIL
...